Rafferty Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.04M | Sell |
181,676
-16,587
| -8% | -$396K | 0.02% | 460 |
|
|
2025
Q4 | $5.3M | Buy |
198,263
+3,232
| +2% | +$77.2K | 0.02% | 420 |
|
|
2025
Q3 | $4.16M | Buy |
195,031
+69,294
| +55% | +$1.64M | 0.01% | 467 |
|
|
2025
Q2 | $2.71M | Sell |
125,737
-74,552
| -37% | -$1.39M | 0.01% | 536 |
|
|
2025
Q1 | $3.33M | Buy |
200,289
+50,055
| +33% | +$909K | 0.01% | 453 |
|
|
2024
Q4 | $2.76M | Sell |
150,234
-135,507
| -47% | -$2.19M | 0.01% | 551 |
|
|
2024
Q3 | $4.39M | Sell |
285,741
-19,338
| -6% | -$323K | 0.02% | 448 |
|
|
2024
Q2 | $4.96M | Sell |
305,079
-86,146
| -22% | -$1.39M | 0.02% | 417 |
|
|
2024
Q1 | $7.23M | Sell |
391,225
-36,705
| -9% | -$909K | 0.03% | 374 |
|
|
2023
Q4 | $13.4M | Buy |
427,930
+91,317
| +27% | +$2.18M | 0.06% | 211 |
|
|
2023
Q3 | $7.02M | Buy |
336,613
+584
| +0.2% | +$15.9K | 0.04% | 322 |
|
|
2023
Q2 | $8.05M | Buy |
336,029
+3,668
| +1% | +$81.5K | 0.05% | 271 |
|
|
2023
Q1 | $6.26M | Sell |
332,361
-224,320
| -40% | -$4.27M | 0.04% | 332 |
|
|
2022
Q4 | $8.86M | Buy |
556,681
+158,005
| +40% | +$2.47M | 0.07% | 217 |
|
|
2022
Q3 | $6.52M | Buy |
398,676
+175,222
| +78% | +$2.84M | 0.07% | 248 |
|
|
2022
Q2 | $3.15M | Sell |
223,454
-7,229
| -3% | -$135K | 0.03% | 379 |
|
|
2022
Q1 | $5.59M | Sell |
230,683
-6,215
| -3% | -$150K | 0.03% | 360 |
|
|
2021
Q4 | $5.53M | Buy |
236,898
+43,230
| +22% | +$869K | 0.03% | 352 |
|
|
2021
Q3 | $3.22M | Buy |
193,668
+98,537
| +104% | +$1.9M | 0.02% | 437 |
|
|
2021
Q2 | $2.32M | Sell |
95,131
-28,091
| -23% | -$634K | 0.01% | 647 |
|
|
2021
Q1 | $3.18M | Buy |
123,222
+105,036
| +578% | +$4.62M | 0.02% | 453 |
|
|
2020
Q4 | $972K | Sell |
18,186
-35,995
| -66% | -$1.79M | 0.01% | 503 |
|
|
2020
Q3 | $2.23M | Buy |
54,181
+33,346
| +160% | +$1.44M | 0.03% | 379 |
|
|
2020
Q2 | $1.01M | Buy |
20,835
+10,427
| +100% | +$501K | 0.01% | 538 |
|
|
2020
Q1 | $440K | Sell |
10,408
-78,071
| -88% | -$3.22M | 0.02% | 361 |
|
|
2019
Q4 | $3.79M | Sell |
88,479
-35,204
| -28% | -$1.53M | 0.06% | 180 |
|
|
2019
Q3 | $4.45M | Sell |
123,683
-77,572
| -39% | -$2.35M | 0.07% | 165 |
|
|
2019
Q2 | $5.38M | Buy |
201,255
+8,735
| +5% | +$223K | 0.09% | 146 |
|
|
2019
Q1 | $5.17M | Buy |
+192,520
| New | +$4.5M | 0.08% | 133 |
|
Other funds holding ACAD
BBA
VPM
RI
VCM
PAI